Cancer Research Horizons
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Infinitopes
21 Jan 2026
Infinitopes secures an £11m seed round led by Octopus Ventures and Amplify Bio to prevent recurrence of oesophageal cancer
Infinitopes develops off-the-shelf precision cancer vaccines designed to prevent recurrence, using AI-powered immunomics to target shared tumour features and advance new immunotherapies into clinical trials.
52North
6 Dec 2024
Oncology medical tech startup 52North secures £5m with landmark UK-US hospital VC deal
52North builds medical devices and digital tools that support cancer patients outside hospital, focusing on early detection and monitoring of treatment-related complications to improve urgent oncology care pathways.
Cancer Research Horizons
More venture news
- 4 Sept 2026
AI ScoreAI Score lands a £4m seed round led by Fuel Ventures to track and control AI usage within organisations
SeedAI - 2 Sept 2026
Ki 13Ki 13 unlocks a £3.7m seed round led by HICO Investment Group to make green hydrogen and CO₂ from biomass
SeedEnergy - 1 Sept 2026
OrchestraOrchestra lands a £2.4m seed round led by Differential Ventures for control plane that runs data pipelines and AI agents together
SeedDeveloper Tools
